| Literature DB >> 27913952 |
Ming-Hui Xu1, Feng-Lai Yuan1, Shu-Jing Wang1, Hui-Ying Xu1, Cheng-Wan Li2, Xiao Tong3.
Abstract
Cytokine-mediated immunity plays a dominant role in the pathogenesis of various immune diseases, including asthma. The recent identification of the family interleukin (IL)-1-related cytokine IL-18 now contributes to our understanding of the fine-tuning of cellular immunity. IL-18 can act as a cofactor for Th2 cell development and IgE production and also plays an important role in the differentiation of Th1 cells. Recent work identified an IL-18 association with the pathogenesis of asthma, wherein increased IL-18 expression was found in the serum of patients. Furthermore, IL-18 polymorphisms with susceptibility to asthma were reported, suggesting that IL-18 may be therapeutically relevant to asthma. In this review, we discuss the role of IL-18 in the pathogenesis of asthma and its therapeutic potential based on current research.Entities:
Keywords: Asthma; IL-18; Th1 cell; Th2 cell
Mesh:
Substances:
Year: 2017 PMID: 27913952 DOI: 10.1007/s10753-016-0467-3
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092